Metsera, Inc. - Common Stock Aktie - Unternehmensdaten & Kurse - US59267L1070 | MoneyPeak

Metsera, Inc. - Common Stock

Share · US59267L1070 · MTSR (XNAS)

Analyst Grade Summary

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

0

3

1

0

0

No Price

n/a

Share Float & Liquidity

Free Float 45,69 %

Shares Float 48,15 M

Shares Outstanding 105,37 M

Company Profile for Metsera, Inc. - Common Stock Share

Metsera, Inc., a clinical-stage biotechnology company, develops injectable and oral nutrient stimulated hormone analog peptides to treat obesity, overweight, and related diseases. It develops MET-097i and MET-233i for the treatment of obesity and overweight; MET-233i/MET-097i; and MET-002, MET-224o, MET-067i, and MET-034i to treat disorders, such as diabetes and obesity. The company was incorporated in 2022 and is headquartered in New York, New York.

Get up to date insights from finAgent about Metsera, Inc. - Common Stock

Company Data

Name Metsera, Inc. - Common Stock

Company Metsera, Inc.

Symbol MTSR

Website https://metsera.com

Primary Exchange

NASDAQ

ISIN US59267L1070

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Christopher Whitten Bernard

Market Capitalization 7 Mrd.

Country United States of America

Currency USD

Employees 0,1 T

Address 3 World Trade Center, 10007 New York City

IPO Date 2025-01-31

Ticker Symbols

Name	Symbol
NASDAQ	MTSR

More Shares

Investors who hold Metsera, Inc. - Common Stock also have the following shares in their portfolio:

IonQ, Inc. Common Stock Share

PLAYFAIR MNG Share

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog

Im App Store herunterladen

Bei Google Play herunterladen

All rights reserved © LCP GmbH 2025